Loading...
Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study
BACKGROUND: Influenza causes substantial morbidity and mortality despite available treatments. Anecdotal reports suggest that plasma with high antibody titres to influenza might be of benefit in the treatment of severe influenza. METHODS: In this randomised, open-label, multicentre, phase 2 trial, 2...
Na minha lista:
| Udgivet i: | Lancet Respir Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier Ltd.
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5828518/ https://ncbi.nlm.nih.gov/pubmed/28522352 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2213-2600(17)30174-1 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|